drugset

drugset / Trial / NCT01046240

Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy

NCT01046240 ↗

Phase 1/2 Completed 29 enrolled Clinica Universidad de Navarra, Universidad de Navarra

Non-randomizedCrossoverOpen-labelPrevention

Summary

This trial compares the pharmacokinetics of palonosetron administered subcutaneously and intravenously.

Timeline

Start: 2009-10
Primary completion: 2010-11
Completion: 2010-11

Publications

Sadaba B, del Barrio A, Campanero MA, Azanza JR, Gomez-Guiu A, Lopez-Picazo JM, Algarra SM, Guillen Grima F, Blanco Prieto M, Perez-Gracia JL, Gurpide A. Randomized pharmacokinetic study comparing subcutaneous and intravenous palonosetron in cancer patients treated with platinum based chemotherapy. PLoS One. 2014 Feb 27;9(2):e89747. doi: 10.1371/journal.pone.0089747. eCollection 2014.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Palonosetron	Other / unclassified	3 mg	Subcutaneous

Indications

No indication recorded.